Royalty Pharma Investments 2019 ICAV - Director, 10%+ Owner at Epizyme, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
EPZM
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Royalty Pharma Investments 2019 ICAV since 9/13/2023

Holdings reported by Royalty Pharma Investments 2019 ICAV for Epizyme, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 22.7M $32M $1.41 Jan 31, 2022 Direct

There are no transactions reported by Royalty Pharma Investments 2019 ICAV for Epizyme, Inc.